Celebrating our 10th anniversary – Unlock our special offer today

Emerald Health prepares to sort the CBD from the chaff

A Canadian CBD firm will use waste from Canada’s newly-legal cannabis industry to make more CBD products.

Emerald Health Therapeutics (EHT) is in the process of signing an agreement with Factors, a nutraceuticals company, to use an extraction facility capable of processing 1000 tonnes of biomass and producing 600m softgel capsules every year.

In order to start feeding this facility, it has also signed an agreement with the subsidiary of one of its shareholders to purchase cannabis chaff for processing.

EHT, 32% owned by Emerald Health Sciences (EHS), will purchase from EHS’s subsidiary Emerald Health Hemp the chaff from 500 acres of harvested hemp.

Read full article
I'm already a subscriber

Freddie Dawson

Managing editor, news
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization